FDA Slammed For Silence On ADHD Warning Labels
A U.S. Senator has criticized the U.S. Food and Drug Administration's decision to require heart and psychiatric warnings on attention deficit drugs without making a public announcement....To view the full article, register now.
Already a subscriber? Click here to view full article